247 related articles for article (PubMed ID: 18223471)
1. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
Nakayama H; Echizen H; Tanaka M; Sato M; Orii T
Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
[TBL] [Abstract][Full Text] [Related]
2. [Initial dosage of vancomycin in neutropenic hematologic patients].
Soto J; Alsar MJ; Sacristán JA
Sangre (Barc); 1992 Jun; 37(3):181-4. PubMed ID: 1440095
[TBL] [Abstract][Full Text] [Related]
3. Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients.
Okamoto G; Sakamoto T; Kimura M; Ukishima Y; Sonoda A; Mori N; Kato Y; Maeda T; Kagawa Y
Clin Biochem; 2007 Apr; 40(7):485-90. PubMed ID: 17336280
[TBL] [Abstract][Full Text] [Related]
4. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA
Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482
[TBL] [Abstract][Full Text] [Related]
6. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Hutschala D; Kinstner C; Skhirdladze K; Thalhammer F; Müller M; Tschernko E
Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
[TBL] [Abstract][Full Text] [Related]
7. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin pharmacokinetics in patients with severe burn injuries.
Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
[TBL] [Abstract][Full Text] [Related]
9. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
[TBL] [Abstract][Full Text] [Related]
10. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
12. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of vancomycin in adult cancer patients.
Al-Kofide H; Zaghloul I; Al-Naim L
J Oncol Pharm Pract; 2010 Dec; 16(4):245-50. PubMed ID: 20015925
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.
Matzke GR; Kovarik JM; Rybak MJ; Boike SC
Clin Pharm; 1985; 4(3):311-5. PubMed ID: 4006395
[TBL] [Abstract][Full Text] [Related]
16. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
Baptista JP; Sousa E; Martins PJ; Pimentel JM
Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic monitoring of vancomycin in critical care pediatric patients].
Zylbersztajn BL; Travaglianti M; Weller G; Mato HG
Arch Argent Pediatr; 2008 Feb; 106(1):26-31. PubMed ID: 18636130
[TBL] [Abstract][Full Text] [Related]
18. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
19. Dosage adjustment of antiinfective therapy in patients with renal impairment.
Eckhardt A; Borner K; Keller F; Zellner D
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
Buck ML
Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
